Not to be applied to potentially malignant or pre-malignant lesions. Not recommended in patients w/ skin barrier defect eg, Netherton's syndrome, lamellar ichthyosis, generalized erythroderma or cutaneous Graft Versus Host disease. Not to be used in patients w/ congenital or acquired immunodeficiencies or on therapy that causes immunosuppression. Exercise care in patients w/ extensive skin involvement over an extended period of time, especially in childn. Clear clinical infections at treatment sites prior to treatment. Minimise skin exposure to sunlight & avoid use of UV light from solarium, therapy w/ UVB or PUVA. Monitor patients who develop lymphadenopathy. Avoid contact w/ eyes & mucous membranes. Not recommended under occlusive dressings. Not to be applied on the same area w/ emollients w/in 2 hr of application. Hepatic failure. Not to be used in childn <2 yr.